🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSemaglutide and MASH — March 2026 Page 7

Semaglutide and MASH — March 2026

sophie_paris Tue, Dec 17, 2024 at 7:15 PM 42 replies 2,138 viewsPage 7 of 9
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
May 20, 2025 at 4:31 PM#31
sophie_paris said:
I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: May 20, 2025 at 9:31 PM
9 7PharmHunterJen, TomTeleRx, DoseLogDan and 6 others
Reply Quote Save Share Report
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Jun 1, 2025 at 9:39 PM#32
sophie_paris said:
I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

Last edited: Jun 2, 2025 at 12:39 AM
10 8hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 7 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Jun 14, 2025 at 2:40 AM#33
sophie_paris said:
I did go to 2.4mg in the end, and the honest report is that it bought me less than the step before it and cost me two bad weeks.

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

Last edited: Jun 14, 2025 at 4:40 AM
11 9FranDenver, Dr.BariatricHTX, LindaRN_retired and 8 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Jun 26, 2025 at 7:34 AM#34

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Jun 26, 2025 at 11:34 AM
12 10DoseLogDan, SleepFixSam, PurityPaulOR and 9 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jul 8, 2025 at 12:21 PM#35
TrialNerd_Beth said:
The useful move here is to separate what is established from what is widely repeated.

Mine went the same way, slower. The detail I would add is minor and it is already implied above.

13 11bbq_ray_KC, oliver_london, tane_welly and 10 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register